TPST DCF Valuation - Tempest Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 1.31 USD -9.66% Market Closed

Market Cap: $19.4m

	Tempest Therapeutics Inc NASDAQ:TPST	US
	Metaplanet Inc OTC:MTPLF	JP
T	Thales SA OTC:THLEF	FR
	DP Eurasia NV LSE:DPEU	NL
R	RENERGEN Ltd JSE:REN	ZA
C	Canadian Tire Corporation Ltd TSX:CTC	CA
	MSA Safety Inc NYSE:MSA	US
	Comfort Systems USA Inc NYSE:FIX	US
	Bristol-Myers Squibb Co NYSE:BMY	US
	S&P Global Inc NYSE:SPGI	US
	Agronomics Ltd LSE:ANIC	IM
F	freenet AG OTC:FRTAY	DE
	Bellring Brands Inc NYSE:BRBR	US
	Forbidden Foods Ltd ASX:OMG	AU
I	Intel Corp DUS:INL	US
	Takeda Pharmaceutical Co Ltd NYSE:TAK	JP
	Q2 Holdings Inc NYSE:QTWO	US
S	Standard Lithium Ltd XTSX:SLI	CA
A	Appen Ltd F:433	AU
	Antofagasta PLC LSE:ANTO	UK
W	WooDeumGeeFarm Co Ltd KOSDAQ:403490	KR
V	ViTrox Corporation Bhd KLSE:VITROX	MY
	Globe Textiles (India) Ltd NSE:GLOBE	IN
S	Sasol Ltd JSE:SOL	ZA

TPST's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.